Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Diagnostics › Molecular Diagnostics › Coronavirus Tests From Fosun Pharma, Osang Healthcare Receive FDA Emergency Use Authorization

Coronavirus Tests From Fosun Pharma, Osang Healthcare Receive FDA Emergency Use Authorization

Apr 20, 2020
|
staff reporter

NEW YORK ─ The US Food and Drug Administration has granted Emergency Use Authorization to Shanghai Fosun Pharmaceutical for its COVID-19 RT-PCR detection kit and Osang Healthcare for its GeneFinder COVID-19 Plus RealAmp Kit.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Nov
10
Featured Webinar

IVDR in Light of the COVID Pandemic: The Near Future of In Vitro Diagnostic Testing

Sponsored by
LGC

The COVID-19 pandemic created a paradigm shift in modern healthcare, where regulations, protocols, and mindsets had to be reworked in just a matter of months to keep up with the pace of the virus.

What's Popular?

In Molecular Diagnostics

  1. FIND Awarded $60M to Expand COVID-19 Testing

  2. Exact Sciences to Acquire Thrive Earlier Detection for up to $2.15B; Q3 Revenues Spike 87 Percent

  3. FDA Approves Foundation Medicine CDx, Bayer's Vitrakvi for NTRK Patients

  4. COVID-19 Testing Plays Into Abbott's Long-Term Diagnostic Strategy

    Premium

  5. Helix Coronavirus Test FDA EUA Reissued to Include Specimen Self-Collection

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.